Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography

Fabien Hyafil; Jean-Christophe Cornily; Jonathan E Feig; Ronald Gordon; Esad Vucic; Vardan Amirbekian; Edward A Fisher; Valentin Fuster; Laurent J Feldman; Zahi A Fayad

doi:10.1038/nm1571

journal article Apr 08, 2007

Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography

Fabien Hyafil Jean-Christophe Cornily Jonathan E Feig Ronald Gordon

Esad Vucic Vardan Amirbekian Edward A Fisher Valentin Fuster Laurent J Feldman Zahi A Fayad

Nature Medicine Vol. 13 No. 5 pp. 636-641 · Springer Science and Business Media LLC

View at Publisher Save 10.1038/nm1571

Topics

No keywords indexed for this article. Browse by subject →

References

35

[1]

Naghavi, M. et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation 108, 1664–1672 (2003). 10.1161/01.cir.0000087480.94275.97

[2]

Pathology of the Vulnerable Plaque

Renu Virmani, Allen P. Burke, Andrew Farb et al.

Journal of the American College of Cardiology 2006 10.1016/j.jacc.2005.10.065

[3]

Libby, P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 104, 365–372 (2001). 10.1161/01.cir.104.3.365

[4]

Fuster, V., Moreno, P.R., Fayad, Z.A., Corti, R. & Badimon, J.J. Atherothrombosis and high-risk plaque: part I: evolving concepts. J. Am. Coll. Cardiol. 46, 937–954 (2005). 10.1016/j.jacc.2005.03.074

[5]

Our Preoccupation With Coronary Luminology

Eric J. Topol, Steven E. Nissen

Circulation 1995 10.1161/01.cir.92.8.2333

[6]

Libby, P. Inflammation in atherosclerosis. Nature 420, 868–874 (2002). 10.1038/nature01323

[7]

Mauriello, A. et al. Diffuse and active inflammation occurs in both vulnerable and stable plaques of the entire coronary tree: a histopathologic study of patients dying of acute myocardial infarction. J. Am. Coll. Cardiol. 45, 1585–1593 (2005). 10.1016/j.jacc.2005.01.054

[8]

Fayad, Z.A. & Fuster, V. Clinical imaging of the high-risk or vulnerable atherosclerotic plaque. Circ. Res. 89, 305–316 (2001). 10.1161/hh1601.095596

[9]

Hoffmann, U. et al. Predictive value of 16-slice multidetector spiral computed tomography to detect significant obstructive coronary artery disease in patients at high risk for coronary artery disease: patient-versus segment-based analysis. Circulation 110, 2638–2643 (2004). 10.1161/01.cir.0000145614.07427.9f

[10]

Leber, A.W. et al. Quantification of obstructive and nonobstructive coronary lesions by 64-slice computed tomography: a comparative study with quantitative coronary angiography and intravascular ultrasound. J. Am. Coll. Cardiol. 46, 147–154 (2005). 10.1016/j.jacc.2005.03.071

[11]

Achenbach, S. et al. Detection of calcified and noncalcified coronary atherosclerotic plaque by contrast-enhanced, submillimeter multidetector spiral computed tomography: a segment-based comparison with intravascular ultrasound. Circulation 109, 14–17 (2004). 10.1161/01.cir.0000111517.69230.0f

[12]

Leber, A.W. et al. Accuracy of 64-slice computed tomography to classify and quantify plaque volumes in the proximal coronary system: a comparative study using intravascular ultrasound. J. Am. Coll. Cardiol. 47, 672–677 (2006). 10.1016/j.jacc.2005.10.058

[13]

Viles-Gonzalez, J.F. et al. In vivo 16-slice, multidetector-row computed tomography for the assessment of experimental atherosclerosis: comparison with magnetic resonance imaging and histopathology. Circulation 110, 1467–1472 (2004). 10.1161/01.cir.0000141732.28175.2a

[14]

Leber, A.W. et al. Accuracy of multidetector spiral computed tomography in identifying and differentiating the composition of coronary atherosclerotic plaques: a comparative study with intracoronary ultrasound. J. Am. Coll. Cardiol. 43, 1241–1247 (2004). 10.1016/j.jacc.2003.10.059

[15]

Schroeder, S. et al. Accuracy and reliability of quantitative measurements in coronary arteries by multi-slice computed tomography: experimental and initial clinical results. Clin. Radiol. 56, 466–474 (2001). 10.1053/crad.2001.0687

[16]

Pohle, K. et al. Characterization of non-calcified coronary atherosclerotic plaque by multi-detector row CT: comparison to IVUS. Atherosclerosis 190, 174–180 (2007). 10.1016/j.atherosclerosis.2006.01.013

[17]

Zhang, Z. et al. Non-invasive imaging of atherosclerotic plaque macrophage in a rabbit model with F-18 FDG PET: A histopathological correlation. BMC Nucl. Med. 6, 3 (2006). 10.1186/1471-2385-6-3

[18]

Helft, G. et al. Progression and regression of atherosclerotic lesions: monitoring with serial noninvasive magnetic resonance imaging. Circulation 105, 993–998 (2002). 10.1161/hc0802.104325

[19]

Aikawa, M. et al. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation 97, 2433–2444 (1998). 10.1161/01.cir.97.24.2433

[20]

Ruehm, S.G., Corot, C., Vogt, P., Kolb, S. & Debatin, J.F. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 103, 415–422 (2001). 10.1161/01.cir.103.3.415

[21]

Hyafil, F. et al. Ferumoxtran-10-enhanced MRI of the hypercholesterolemic rabbit aorta: relationship between signal loss and macrophage infiltration. Arterioscler. Thromb. Vasc. Biol. 26, 176–181 (2006). 10.1161/01.atv.0000194098.82677.57

[22]

Accumulation of Ultrasmall Superparamagnetic Particles of Iron Oxide in Human Atherosclerotic Plaques Can Be Detected by In Vivo Magnetic Resonance Imaging

M.E. Kooi, V.C. Cappendijk, K.B.J.M. Cleutjens et al.

Circulation 2003 10.1161/01.cir.0000068315.98705.cc

[23]

Trivedi, R.A. et al. In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI. Stroke 35, 1631–1635 (2004). 10.1161/01.str.0000131268.50418.b7

[24]

Rudd, J.H. et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 105, 2708–2711 (2002). 10.1161/01.cir.0000020548.60110.76

[25]

Dunphy, M.P., Freiman, A., Larson, S.M. & Strauss, H.W. Association of vascular 18F-FDG uptake with vascular calcification. J. Nucl. Med. 46, 1278–1284 (2005).

[26]

Wisner, E.R. et al. Iodinated nanoparticles for indirect computed tomography lymphography of the craniocervical and thoracic lymph nodes in normal dogs. Acad. Radiol. 1, 377–384 (1994). 10.1016/s1076-6332(12)80012-2

[27]

McIntire, G.L. et al. Time course of nodal enhancement with CT X-ray nanoparticle contrast agents: effect of particle size and chemical structure. Invest. Radiol. 35, 91–96 (2000). 10.1097/00004424-200002000-00001

[28]

Krause, W. Delivery of diagnostic agents in computed tomography. Adv. Drug Deliv. Rev. 37, 159–173 (1999). 10.1016/s0169-409x(98)00105-7

[29]

An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles

Oded Rabin, J. Manuel Perez, Jan Grimm et al.

Nature Materials 2006 10.1038/nmat1571

[30]

Mukundan, S., Jr. et al. A liposomal nanoscale contrast agent for preclinical CT in mice. AJR Am. J. Roentgenol. 186, 300–307 (2006). 10.2214/ajr.05.0523

[31]

Zheng, J., Perkins, G., Kirilova, A., Allen, C. & Jaffray, D.A. Multimodal contrast agent for combined computed tomography and magnetic resonance imaging applications. Invest. Radiol. 41, 339–348 (2006). 10.1097/01.rli.0000186568.50265.64

[32]

Fu, Y. et al. Dendritic iodinated contrast agents with PEG-cores for CT imaging: synthesis and preliminary characterization. Bioconjug. Chem. 17, 1043–1056 (2006). 10.1021/bc060019c

[33]

Gupta, R. et al. Ultra-high resolution flat-panel volume CT: fundamental principles, design architecture, and system characterization. Eur. Radiol. 16, 1191–1205 (2006). 10.1007/s00330-006-0156-y

[34]

Flohr, T.G. et al. First performance evaluation of a dual-source CT (DSCT) system. Eur. Radiol. 16, 256–268 (2006). 10.1007/s00330-005-2919-2

[35]

Boll, D.T. et al. Spectral coronary multidetector computed tomography angiography: dual benefit by facilitating plaque characterization and enhancing lumen depiction. J. Comput. Assist. Tomogr. 30, 804–811 (2006). 10.1097/01.rct.0000228162.70849.26

Cited By

397

Emerging Head and Neck Tumor Targeting Contrast Agents for the Purpose of CT, MRI, and Multimodal Diagnostic Imaging: A Molecular Review

Jonathan M. Neilio, Daniel T. Ginat · 2024

Diagnostics

Ligand-Specific Nano-Contrast Agents Promote Enhanced Breast Cancer CT Detection at 0.5 mg Au

Kalyan Ramesh, Alice Truong · 2022

International Journal of Molecular...

Comprehensive plaque assessment by coronary CT angiography

Pal Maurovich-Horvat, Maros Ferencik · 2014

Nature Reviews Cardiology

Metrics

397

Citations

35

References

Details

Published: Apr 08, 2007
Vol/Issue: 13(5)
Pages: 636-641
License: View

Authors

F

Fabien Hyafil

J

Jean-Christophe Cornily

BioMedical Engineering & Imaging Institute, Icahn School of Medicine at Mt Sinai , Gustave L. Levy Place, New York, NY 10029-5674, USA

Cite This Article

Fabien Hyafil, Jean-Christophe Cornily, Jonathan E Feig, et al. (2007). Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. Nature Medicine, 13(5), 636-641. https://doi.org/10.1038/nm1571

Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography

You May Also Like